Article
Merck's Keytruda fails to meet one main goal in gastric cancer trial
Rating:
0.0
Views:
80
Likes:
1
Library:
1
Merck & Co said on Tuesday its blockbuster immunotherapy Keytruda failed to meet one of the two main goals in a late-stage study testing it as a treatment option for a type of advanced gastric cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value